Lucid Diagnostics Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Firm Advances Commercial Rollout NMRA Q1 2026 Earnings NarrowerthanExpected Loss Reflects Disciplined Spending ABXL Q1 2026 Earnings EPS Just Below Estimates Amid Stable Operations ROC Q1 2026 Earnings Surprise Profit Beats Estimates Despite Tepid Market Response Alexanders Inc ALX Q1 2026 Earnings Solid EPS Performance Amid Market Uncertainty Unicycive Therapeutics UNCY Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues Development